CONFLUENCESTAT, LLC
COOPER CITY, FLORIDA

ConfluenceStat, LLC operates as a specialized consultancy providing an array of services focused on the independent evaluation of clinical trials for investors or potential investors. Founded by Dr. Jason Connor, who brings over 11 years of experience in designing more than 200 Bayesian adaptive and platform trials, the company leverages Dr. Connor's extensive background with regulatory bodies like the FDA’s Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), and Center for Devices and Radiological Health (CDRH). Core services include employing clinical trial simulation techniques to scrutinize design assumptions, aiming to replicate power and sample size calculations. Furthermore, ConfluenceStat conducts thorough sensitivity analyses and stress tests on trial designs to score their reliability. The consultancy offers predictive probabilities of trial success when deviations from initial assumptions occur. In addition to its core evaluation services, the company provides other expert consulting solutions within the clinical research domain. Established in Cooper City, Florida, under the business filing number L17000127973 as a Florida Limited Liability Company (FLAL), ConfluenceStat was officially incorporated on June 12, 2017. The company previously operated as TRIALDX, LLC and updated its designation on July 12, 2017. Its mailing address is located at 3102 NW 82nd Way, Cooper City, FL, 33024, United States, with contact information available through the phone number (412) 860-3113 or via their website, trialdx.com. The most recent significant reporting update was last made on January 8, 2024, for the year-end annual report covering 2024. Dr. Jason Connor serves as the manager and is among its key officers and directors.